21 CFR Part 11, Exceeding Standards
Over the course of 2017 and 2018, DYNALABS has invested hundreds of thousands of dollars, and increased its’ focus on data integrity, information security, and software validation processes. This will ensure we not only meet, but exceed, FDA standards for 21 CFR Part 11.
Additionally, we have made improvements to the DVx, our on-site testing solution, to support client growth, and to seamlessly execute future software updates through the cloud.
Lastly, we have begun working on improvements to our data structure and sample submission process, and are developing a new product configuration tool, that will increase both efficiency and accuracy of products submitted by our clients. |